XALKORI 50 MG GRANULADO EN CAPSULAS PARA ABRIR
XALKORI 50 MG GRANULADO EN CAPSULAS PARA ABRIR
Commercialized
Register Number
112793006
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Sep 20, 2024
Dosage Form
GRANULADO EN CAPSULAS PARA ABRIR
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number112793006
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
CRIZOTINIBActive
Quantity: 50 mg
Name: CRIZOTINIB
ATC CLASSIFICATION (3)
L01E
L01ED
L01ED01